Search Within

Sridevi Rajeeve

Formats
  1. Meeting Abstract (26)
  2. Journal Article (5)
  3. Review (2)
  4. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (28)
  2. Department of Medicine (28)
  3. Hematologic Malignancies, Division of (28)
  4. Myeloma (28)
  5. Bone Marrow Transplant (26)
  6. CTCR Scholars (26)

More Groups

People
  1. Sham Mailankody (28)
  2. Saad Usmani (27)
  3. Alexander Lesokhin (26)
  4. Carlyn Rose Tan (26)
  5. David Chung (26)
  6. Heather Landau (26)

More People

Years
  1. 2025 (2)
  2. 2024 (26)
  3. 2023 (6)
Publications
  1. Blood (14)
  2. Clinical Lymphoma, Myeloma and Leukemia (11)
  3. Blood Advances (2)
  4. Journal of Clinical Oncology (2)
  5. American Journal of Hematology (1)
  6. Blood Cancer Journal (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. Elsevier Inc. (11)
  3. American Society of Clinical Oncology (2)
  4. Frontiers Media S.A. (1)
  5. John Wiley & Sons (1)
  6. Nature Publishing Group (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The landscape of clinical trials for heavily pretreated multiple myeloma: Opportunity for more randomization?
    Correspondence

    Kapur, R.; McCarron, J.; Rajeeve, S.; Mohyuddin, G. R.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Addition of elotuzumab to backbone treatment regimens for multiple myeloma: An updated meta-analysis of randomized clinical trials
    Journal Article

    Costa, B. A.; Costa, T. A.; Chagas, G. C. L.; Mouhieddine, T. H.; Richter, J.; Usmani, S. Z.; Mailankody, S.; Rajeeve, S.; Hashmi, H.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease
    Meeting Abstract

    Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world safety and early efficacy of talquetamab in patients with heavily-pretreated relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B. A.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Defining the rates of cytokine release syndrome associated with talquetamab step-up doses
    Meeting Abstract

    Hamadeh, I. S.; Shekarkhand, T.; Rueda, C.; Firestone, R. S.; Wang, A. X.; Korde, N.; Hultcrantz, M.; Lesokhin, A. M.; Mailankody, S.; Hassoun, H.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparison of acute kidney injury in patients with relapsed or refractory multiple myeloma following CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Farzana, T.; Shaikh, A.; Latcha, S.; Gutgarts, V.; Jurgens, E. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Manufacture of anti-BCMA CAR T cell is feasible after salvage autologous or allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Perica, K.; Nagel, K.; Payson, E.; Hosszu, K. K.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Delayed neurotoxicity after CAR-T in multiple myeloma: Results from a global IMWG registry
    Meeting Abstract

    Kumar, A. D.; Atallah-Yunes, S. A.; Rajeeve, S.; Abdelhak, A.; Hashmi, H.; Corraes, A.; Htut, M.; Rodriguez-Otero, P.; Parrondo, R. D.; Chhabra, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Frailty and outcomes after bispecific T-cell engager therapy for patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Adegbite, B. O.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood (2024)

    Fulltext@MSK | Save